157 related articles for article (PubMed ID: 18334281)
1. E2F1 in gliomas: a paradigm of oncogene addiction.
Alonso MM; Alemany R; Fueyo J; Gomez-Manzano C
Cancer Lett; 2008 May; 263(2):157-63. PubMed ID: 18334281
[TBL] [Abstract][Full Text] [Related]
2. Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors.
Olson MV; Johnson DG; Jiang H; Xu J; Alonso MM; Aldape KD; Fuller GN; Bekele BN; Yung WK; Gomez-Manzano C; Fueyo J
Cancer Res; 2007 May; 67(9):4005-9. PubMed ID: 17483310
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive assessment of E2F-1-mediated transcriptional regulation in vivo.
Monfared P; Winkeler A; Klein M; Li H; Klose A; Hoesel M; Waerzeggers Y; Korsching S; Jacobs AH
Cancer Res; 2008 Jul; 68(14):5932-40. PubMed ID: 18632648
[TBL] [Abstract][Full Text] [Related]
4. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
[TBL] [Abstract][Full Text] [Related]
5. Gene expression phenotypic models that predict the activity of oncogenic pathways.
Huang E; Ishida S; Pittman J; Dressman H; Bild A; Kloos M; D'Amico M; Pestell RG; West M; Nevins JR
Nat Genet; 2003 Jun; 34(2):226-30. PubMed ID: 12754511
[TBL] [Abstract][Full Text] [Related]
6. Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer.
Reimer D; Sadr S; Wiedemair A; Goebel G; Concin N; Hofstetter G; Marth C; Zeimet AG
Ann N Y Acad Sci; 2006 Dec; 1091():270-81. PubMed ID: 17341621
[TBL] [Abstract][Full Text] [Related]
7. ICOVIR-5 shows E2F1 addiction and potent antiglioma effect in vivo.
Alonso MM; Cascallo M; Gomez-Manzano C; Jiang H; Bekele BN; Perez-Gimenez A; Lang FF; Piao Y; Alemany R; Fueyo J
Cancer Res; 2007 Sep; 67(17):8255-63. PubMed ID: 17804740
[TBL] [Abstract][Full Text] [Related]
8. Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice.
Iglesias A; Murga M; Laresgoiti U; Skoudy A; Bernales I; Fullaondo A; Moreno B; Lloreta J; Field SJ; Real FX; Zubiaga AM
J Clin Invest; 2004 May; 113(10):1398-407. PubMed ID: 15146237
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism.
Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D
J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166
[TBL] [Abstract][Full Text] [Related]
10. EGFR signaling inhibits E2F1-induced apoptosis in vivo: implications for cancer therapy.
Ginsberg D
Sci STKE; 2007 Jan; 2007(371):pe4. PubMed ID: 17264315
[TBL] [Abstract][Full Text] [Related]
11. The E2F family and the role of E2F1 in apoptosis.
Wu Z; Zheng S; Yu Q
Int J Biochem Cell Biol; 2009 Dec; 41(12):2389-97. PubMed ID: 19539777
[TBL] [Abstract][Full Text] [Related]
12. Rb inactivation leads to E2F1-mediated DNA double-strand break accumulation.
Pickering MT; Kowalik TF
Oncogene; 2006 Feb; 25(5):746-55. PubMed ID: 16186801
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of E2F family members in ovarian cancer--an evaluation in a training set of 77 patients.
Reimer D; Sadr S; Wiedemair A; Stadlmann S; Concin N; Hofstetter G; Müller-Holzner E; Marth C; Zeimet AG
Clin Cancer Res; 2007 Jan; 13(1):144-51. PubMed ID: 17200349
[TBL] [Abstract][Full Text] [Related]
14. E2Fs mediate a fundamental cell-cycle deregulation in high-grade serous ovarian carcinomas.
De Meyer T; Bijsmans IT; Van de Vijver KK; Bekaert S; Oosting J; Van Criekinge W; van Engeland M; Sieben NL
J Pathol; 2009 Jan; 217(1):14-20. PubMed ID: 18991331
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel E2F1 target genes regulated in cell cycle-dependent and independent manners.
Iwanaga R; Komori H; Ishida S; Okamura N; Nakayama K; Nakayama KI; Ohtani K
Oncogene; 2006 Mar; 25(12):1786-98. PubMed ID: 16288221
[TBL] [Abstract][Full Text] [Related]
16. E2F-like elements in p27(Kip1) promoter specifically sense deregulated E2F activity.
Ozono E; Komori H; Iwanaga R; Ikeda MA; Iseki S; Ohtani K
Genes Cells; 2009 Jan; 14(1):89-99. PubMed ID: 19077036
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1.
Jenal M; Trinh E; Britschgi C; Britschgi A; Roh V; Vorburger SA; Tobler A; Leprince D; Fey MF; Helin K; Tschan MP
Mol Cancer Res; 2009 Jun; 7(6):916-22. PubMed ID: 19491197
[TBL] [Abstract][Full Text] [Related]
18. E2F regulates DDB2: consequences for DNA repair in Rb-deficient cells.
Prost S; Lu P; Caldwell H; Harrison D
Oncogene; 2007 May; 26(24):3572-81. PubMed ID: 17173070
[TBL] [Abstract][Full Text] [Related]
19. Oncogenes and glial tumors.
Watkins D; Rouleau GA
Rev Neurol (Paris); 1992; 148(6-7):402-7. PubMed ID: 1448659
[TBL] [Abstract][Full Text] [Related]
20. Evidence of a tumour suppressive function of E2F1 gene in human breast cancer.
Worku D; Jouhra F; Jiang GW; Patani N; Newbold RF; Mokbel K
Anticancer Res; 2008; 28(4B):2135-9. PubMed ID: 18751386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
